Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Clinical Logic: In such cases, GLP-1 therapy should be introduced early as an adjunct to LSM rather than a last-resort measure
The Initial Phase: Weeks 1-4 During the first several weeks on the lowest dose, most people notice a subtle reduction in appetite, feeling fuller sooner during meals, and less interest in snacking
Follow-up check-ins take place every three months
PG-102 and placebo were identical in appearance and administered in the same manner to maintain blinding
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it helps people manage their blood sugar levels
US$ 22.69
US$ 21.13
US$ 24.51
US$ 24.66
